Prolocor

company

About

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$3.20M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.

Prolocor was founded in 2020 and is based in Philadelphia, PA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.20M
Prolocor has raised a total of $3.20M in funding over 2 rounds. Their latest funding was raised on Aug 16, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 16, 2022 Seed $3.20M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Prolocor is funded by 1 investors. LabCorp are the most recent investors.
Investor Name Lead Investor Funding Round
LabCorp Seed